መነሻSNY • NASDAQ
add
Sanofi SA
የቀዳሚ መዝጊያ
$47.98
የቀን ክልል
$47.99 - $48.54
የዓመት ክልል
$45.22 - $58.97
የገበያው አጠቃላይ ዋጋ
122.33 ቢ USD
አማካይ መጠን
2.12 ሚ
ዜና ላይ
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(EUR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 14.16 ቢ | 11.49% |
የሥራ ወጪ | 5.99 ቢ | 11.39% |
የተጣራ ገቢ | 2.82 ቢ | 11.49% |
የተጣራ የትርፍ ክልል | 19.88 | -0.05% |
ገቢ በሼር | 1.54 | -39.43% |
EBITDA | 4.91 ቢ | 15.96% |
ውጤታማ የግብር ተመን | 20.58% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(EUR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 6.80 ቢ | -14.99% |
አጠቃላይ ንብረቶች | — | — |
አጠቃላይ ተጠያቂነቶች | — | — |
አጠቃላይ እሴት | 73.00 ቢ | — |
የሼሮቹ ብዛት | 1.25 ቢ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 0.83 | — |
የእሴቶች ተመላሽ | — | — |
የካፒታል ተመላሽ | 10.54% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(EUR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | 2.82 ቢ | 11.49% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | — | — |
ገንዘብ ከኢንቨስትመንት | — | — |
ገንዘብ ከፋይናንስ | — | — |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | — | — |
ነፃ የገንዘብ ፍሰት | — | — |
ስለ
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
1973
ዋና መሥሪያ ቤት
ድህረገፅ
ሠራተኞች
86,088